Cargando…
Organoids as an Enabler of Precision Immuno-Oncology
Since the dawn of the past century, landmark discoveries in cell-mediated immunity have led to a greater understanding of the innate and adaptive immune systems and revolutionised the treatment of countless diseases, including cancer. Today, precision immuno-oncology (I/O) involves not only targetin...
Autores principales: | Zhao, Junzhe, Fong, Antoinette, Seow, See Voon, Toh, Han Chong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136954/ https://www.ncbi.nlm.nih.gov/pubmed/37190074 http://dx.doi.org/10.3390/cells12081165 |
Ejemplares similares
-
Precision Immuno-Oncology: Prospects of Individualized Immunotherapy for Pancreatic Cancer
por: Zhang, Jiajia, et al.
Publicado: (2018) -
Integration of Genomic Profiling and Organoid Development in Precision Oncology
por: Yoon, Hyunho, et al.
Publicado: (2021) -
Patient-Derived Cancer Organoids for Precision Oncology Treatment
por: Pernik, Mark N., et al.
Publicado: (2021) -
Precision Tools in Immuno-Oncology: Synthetic Gene Circuits for Cancer Immunotherapy
por: Bonfá, Giuliano, et al.
Publicado: (2020) -
The immuno-oncology framework: Enabling a new era of cancer therapy
por: Hoos, Axel, et al.
Publicado: (2012)